Gerresheimer Past Earnings Performance

Past criteria checks 4/6

Gerresheimer has been growing earnings at an average annual rate of 13.4%, while the Life Sciences industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 9.6% per year. Gerresheimer's return on equity is 8%, and it has net margins of 5.7%.

Key information

13.4%

Earnings growth rate

11.7%

EPS growth rate

Life Sciences Industry Growth21.5%
Revenue growth rate9.6%
Return on equity8.0%
Net Margin5.7%
Next Earnings Update26 Feb 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Gerresheimer makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:GRRM.Y Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Aug 242,01211436819
31 May 242,00211536815
29 Feb 241,99911737213
30 Nov 231,99011637316
31 Aug 231,97410738019
31 May 231,95910737823
28 Feb 231,9049736826
30 Nov 221,8179635122
31 Aug 221,7259133617
31 May 221,6348231415
28 Feb 221,5668529812
30 Nov 211,4988428510
31 Aug 211,465862788
31 May 211,432932728
28 Feb 211,418942729
30 Nov 201,419892758
31 Aug 201,385-252757
31 May 201,394-322755
29 Feb 201,388-142731
30 Nov 191,392812730
31 Aug 191,4152072730
31 May 191,4102072700
28 Feb 191,3861792650
30 Nov 181,3681292590
31 Aug 181,3511242580
31 May 181,3291312560
28 Feb 181,3361372580
30 Nov 171,3481012590
31 Aug 171,331492570
31 May 171,350532590
28 Feb 171,358562580
30 Nov 161,375582590
31 Aug 161,2991182430
31 May 161,2921062400
29 Feb 161,301992380
30 Nov 151,283962310
31 Aug 151,335692360
31 May 151,315692350
28 Feb 151,294682300
30 Nov 141,290662280
31 Aug 141,282712350
31 May 141,275712310
28 Feb 141,267632350

Quality Earnings: GRRM.Y has high quality earnings.

Growing Profit Margin: GRRM.Y's current net profit margins (5.7%) are higher than last year (5.4%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: GRRM.Y's earnings have grown by 13.4% per year over the past 5 years.

Accelerating Growth: GRRM.Y's earnings growth over the past year (6.4%) is below its 5-year average (13.4% per year).

Earnings vs Industry: GRRM.Y earnings growth over the past year (6.4%) exceeded the Life Sciences industry -4.7%.


Return on Equity

High ROE: GRRM.Y's Return on Equity (8%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 21:25
End of Day Share Price 2024/12/13 00:00
Earnings2024/08/31
Annual Earnings2023/11/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Gerresheimer AG is covered by 35 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gaurav JainBarclays
Victoria LambertBerenberg
Scott BardoBerenberg